Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Philips NV
  6. News
  7. Summary
    PHIA   NL0000009538

PHILIPS NV

(PHIA)
  Report
Real-time Euronext Amsterdam  -  11:35 2022-12-02 am EST
14.50 EUR   +1.46%
11/30Royal Philips, MagCorp Team Up to Explore New Magnet Technologies for MRI Scanners
MT
11/30Philips Signs Research Agreement to Explore New Magnet Technologies
BU
11/30Royal Philips N.V. Signs Research Agreement to Explore New Magnet Technologies
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

PHILIPS NV : Sell rating from JP Morgan

09/27/2022 | 06:10am EST

The analyst from JP Morgan, David Adlington, maintains his advice to sell. The target price remains set at EUR 18.80.


ę MarketScreener with dpa-AFX Analyser 2022
All news about PHILIPS NV
11/30Royal Philips, MagCorp Team Up to Explore New Magnet Technologies for MRI Scanners
MT
11/30Philips Signs Research Agreement to Explore New Magnet Technologies
BU
11/30Royal Philips N.V. Signs Research Agreement to Explore New Magnet Technologies
CI
11/28Philips debuts new AI-enhanced informatics solutions to increase diagnostic confidence ..
GL
11/28Philips debuts new AI-enhanced informatics solutions to increase diagnostic confidence ..
GL
11/28Philips launches new compact ultrasound system at RSNA 2022, allowing first-time-right ..
GL
11/28Philips launches new compact ultrasound system at RSNA 2022, allowing first-time-right ..
AQ
11/28PHILIPS NV : UBS reiterates its Neutral rating
MD
11/27Philips advances AI-powered diagnostic systems and transformative workflow solutions at..
AQ
11/27Philips advances AI-powered diagnostic systems and transformative workflow solutions at..
GL
More news
Analyst Recommendations on PHILIPS NV
More recommendations
Financials
Sales 2022 17 374 M 18 217 M 18 217 M
Net income 2022 -1 445 M -1 515 M -1 515 M
Net Debt 2022 5 815 M 6 098 M 6 098 M
P/E ratio 2022 -10,9x
Yield 2022 5,52%
Capitalization 12 838 M 13 461 M 13 461 M
EV / Sales 2022 1,07x
EV / Sales 2023 1,03x
Nbr of Employees 78 831
Free-Float 99,4%
Chart PHILIPS NV
Duration : Period :
Philips NV Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHILIPS NV
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 14,50 €
Average target price 15,91 €
Spread / Average Target 9,69%
EPS Revisions
Managers and Directors
Roy Jakobs President & Chief Executive Officer
Abhijit Bhattacharya Chief Financial Officer & Executive Vice President
Feike Sijbesma Chairman-Supervisory Board
Jan Kimpen Chief Medical Officer
Shez Partovi Chief Medical, Innovation & Strategy Officer
Sector and Competitors
1st jan.Capi. (M$)
PHILIPS NV-55.75%13 461
THERMO FISHER SCIENTIFIC-15.62%221 849
DANAHER CORPORATION-16.65%199 629
INTUITIVE SURGICAL, INC.-23.60%96 209
BOSTON SCIENTIFIC CORPORATION8.57%66 746
SIEMENS HEALTHINEERS AG-21.63%60 480